FDA Drug Application (202766) for POLYMYXIN B SULFATE by XELLIA PHARMS APS

Back to FDA Applications sponsored by XELLIA PHARMS APS

Application Number202766
Product Number001
FormINJECTABLE;INJECTION
DosageEQ 500,000 UNITS BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NamePOLYMYXIN B SULFATE
Active IngredientPOLYMYXIN B SULFATE

Active IngredientCount
List of drugs with Active Ingredient POLYMYXIN B SULFATE46


Back to FDA Applications sponsored by XELLIA PHARMS APS